Adenosine Signaling as a Central Integrative Network in Cellular Stress Responses and a Therapeutically Actionable Target in Human Disease
Authors:
- Shakta Mani SatyamShakta Mani Satyam
- Mohamed El-TananiMEMohamed El-Tanani
- Wasim Iyad AlghoulWAWasim Iyad Alghoul
- Malak Moones AbediMAMalak Moones Abedi
- Shabil Fathah FarookSFShabil Fathah Farook
- Ibrahim Khalil AlabidIAIbrahim Khalil Alabid
- Mohammed DalbahMDMohammed Dalbah
- Natasha NasserNNNatasha Nasser
- Samreen FazalSFSamreen Fazal
- Mariam Radhi Al-TalqaniMAMariam Radhi Al-Talqani
- Mohammed Mahmood AliMAMohammed Mahmood Ali
- Ebrahim SafaiiESEbrahim Safaii
Open Access
- 16 May 2026
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 16 (5) , 732
Abstract
Adenosine has emerged as a central metabolic signal linking cellular stress to systemic physiological adaptation. Under conditions such as hypoxia, ischemia, inflammation, and tissue injury, extracellular adenosine triphosphate (eATP) released from stressed cells is sequentially metabolized by the ectonucleotidases CD39 and CD73, generating adenosine that accumulates in the extracellular microenvironment. This stress-responsive nucleoside activates four G-protein-coupled receptors (A1, A2A, A2B, and A3), triggering intracellular signaling networks including the cyclic adenosine monophosphate–protein kinase A (cAMP–PKA), mitogen-activated protein kinase (MAPK), phosphoinositide 3-kinase–protein kinase B (PI3K–Akt), and hypoxia-inducible factor-1 alpha (HIF-1α) pathways. Through these integrated mechanisms, adenosine orchestrates diverse physiological processes such as vascular regulation, metabolic adaptation, immune modulation, and cellular survival. In the cardiovascular system, adenosine promotes coronary vasodilation and ischemic preconditioning, limiting reperfusion injury. In pulmonary tissues, it mediates acute anti-inflammatory responses but may also drive chronic fibrotic remodeling. Within the central nervous system, adenosine functions as a neuromodulator regulating neuronal excitability, sleep–wake homeostasis, and neuroprotection. In the tumor microenvironment, hypoxia-driven adenosine accumulation suppresses cytotoxic T cell and natural killer activity, facilitating immune evasion and tumor progression. Collectively, adenosine signaling represents a central integrative network that links metabolic stress sensing to coordinated cellular adaptation while simultaneously emerging as a clinically actionable therapeutic target across cardiovascular, inflammatory, neurological, and oncological diseases.Keywords
This publication has 243 references indexed in Scilit:
- Acute Myocardial Infarction: Molecular Pathogenesis, Diagnosis, and Clinical ManagementMedcomm, 2025
- Protein Ubiquitination Modification in Pulmonary FibrosisComprehensive Physiology, 2025
- Dysregulation of Astrocytic ATP/Adenosine Release in the Hippocampus Cause Cognitive and Affective Disorders: Molecular Mechanisms, Diagnosis, and TherapyMedcomm, 2025
- Targeting the Adenosine‐Mediated Metabolic Immune Checkpoint with Engineered Probiotic for Enhanced Chemo‐ImmunotherapyAdvanced Science, 2025
- Glutamate and excitotoxicity in central nervous system disorders: ionotropic glutamate receptors as a target for neuroprotectionNeuroprotection, 2024
- Integrated Functions of Cardiac Energetics, Mechanics, and Purine Nucleotide MetabolismComprehensive Physiology, 2024
- The Complex Roles of Adenosine Triphosphate in BioenergeticsChemBioChem, 2022
- The Antifibrotic Effect of A2B Adenosine Receptor Antagonism in a Mouse Model of Dermal FibrosisArthritis & Rheumatology, 2018
- Therapeutic potentials of adenosine receptors agonists and antagonists in colitis; Current status and perspectivesJournal of Cellular Physiology, 2017
- Adenosine A2A receptor antagonist istradefylline (KW‐6002) reduces “off” time in Parkinson's disease: A double‐blind, randomized, multicenter clinical trial (6002‐US‐005)Annals of Neurology, 2008